ABVX
Abivax S.A.
Next earnings Sep 21, 2026 · consensus $-1.83 EPS, $2.55M rev
$144.65
▲ —$144.65▲ +1854.73%
over 1Y
L $7.40H $145.31
Today—
1W+56.6%
1M+99.5%
3M+22.2%
YTD+8.1%
1Y—
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 14 analysts
Buy
Mixed signals in the latest filings.
Abivax S.A. shows limited reported revenue.
On these fundamentals, ABVX screens as SELL on the SEC figures.
Is ABVX a buy? The one-page verdict, explained →
The options angle
model · matches our verdictBear put spread~60d expiry
- Long put 145 @ ~45.60 est
- Short put 130 @ ~36.17 est
debit $943max +$557max −$943BE 135.57
SELL verdict, defined risk: profits into weakness down to the short strike; max loss is the net debit.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
Financials · annual, by fiscal year
No income data filed.
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$11.5B
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield—
FCF yield—
Quality & risk
ROIC (est.)—
Free cash flow—
Total debt—
Net cash—
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+24.0%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Recent filings
all on EDGAR ↗6-KPeriod ending 2026-07-022026-07-02open ↗424B5Filing2026-07-02open ↗FWPFiling2026-07-01open ↗FWPFiling2026-06-30open ↗424B5Filing2026-06-30open ↗POSASRFiling2026-06-30open ↗6-KPeriod ending 2026-06-292026-06-29open ↗6-KPeriod ending 2026-06-012026-06-02open ↗6-KPeriod ending 2026-03-312026-05-22open ↗6-KPeriod ending 2026-05-202026-05-20open ↗SCHEDULE 13D/AFiling2026-05-11open ↗6-KPeriod ending 2026-05-072026-05-07open ↗
Frequently asked
- Is Abivax S.A. (ABVX) a buy?
- ABVX currently carries a Sell rating with 2/5 conviction, derived from its latest SEC filings. Mixed signals in the latest filings.
- What is Abivax S.A.'s quality score?
- ABVX scores 89.66414655423088/100 (grade A) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001956827, latest 6-K filed 2026-07-02) · EODHD · as of 7/5/2026, 2:54:30 AM.
About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice
Rule-based analysis, generated automatically from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 4, 2026, 10:54 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.